Donald Trump

• Here are the 3 big things we're watching in the stock market in the week ahead - The new year on Wall Street officially kicks into high gear this week.
• Fractures are starting to show in Trump's GOP at the start of this election year - For House Republicans, the political year started with a pep rally of sorts as President Donald Trump gathered them at Washington's Kennedy Center for a stemwinder of a speech. From pushback to Trump's self-described “Donroe doctrine” of a
• This MAGA Fan Is Begging For Advice After Being Cut Off By Their Friends Due To Their Trump Vote, And People Are Not Exactly Sympathetic - "It was maybe true twenty years ago that you could vote for a Republican candidate while your best friend voted Democrat, and it wouldn’t be a big deal. That’s no longer the world we live in."
• Trump is weighing options against Iran: Reports - Iran has said it will retaliate if the U.S. intervenes amid political unrest in the Middle East country.
• Reference to Trump's impeachments is removed from the display of his Smithsonian photo portrait - President Donald Trump's photo portrait display at the Smithsonian's National Portrait Gallery has had references to his two impeachments removed, the latest apparent change at the collection of museums he has accused of bias as he asserts
• UK says NATO talks on deterring Russia in the Arctic 'business as usual' - LONDON, Jan 11 () - Britain said on Sunday discussions with other NATO members on deterring Russian activity in the Arctic were "business as usual", after media reports the ​UK was in talks with its European allies about deploying a militar
• Analysis-With Venezuela raid, US tells China to keep away from the Americas - WASHINGTON, Jan 11 (Reuters) - Among the many goals of last week's U.S. military operation that captured Venezuelan President Nicolas Maduro was to send China a message: stay away from the Americas.
• 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market - Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
• How we navigated the market’s winning week amid Trump's Truth Social surprises - Wall Street shook off a barrage of uncertainty.
• Trump faces headwinds on Venezuela, health care as some Republicans break rank - A White House official said Republicans breaking with the president represent a "tiny fraction" of the congressional GOP.